Clinical Trial Update: Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates high-dose chemotherapy with bone marrow or stem cell transplant for rare poor-prognosis cancers. The study includes Wilms tumor, fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Fibrosarcoma
• Nasopharyngeal Carcinoma
• Wilms Tumor

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Wilms Tumor, Fibrosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-20